Cure My Disease

Don't miss your cure!

 Log in / Sign up

Researchers look back at bladder cancer treatment results in japan

NCT ID NCT06412848

Ongoing Knowledge-focused Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany Source: ClinicalTrials.gov ↗

Summary

This study looks back at medical records of 360 Japanese patients with advanced bladder cancer who received avelumab maintenance therapy after initial chemotherapy. Researchers want to understand patient characteristics, treatment patterns, and survival outcomes. The study doesn't test new treatments but analyzes existing data to learn how this therapy works in real-world Japanese patients.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for UROTHELIAL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Akita University Hospital

    Akita, 010-0041, Japan

  • Ehime University Hospital

    Tōon, Ehime, 791-0295, Japan

  • Hirosaki University Hospital

    Hirosaki, Aomori, 036-8563, Japan

  • Hokkaido University Hospital

    Sapporo, Hokkaido, 060-8648, Japan

  • Iwate Medical University Hospital

    Shiwa-gun, Iwate, 028-3695, Japan

  • Juntendo University Hospital

    Bunkyō City, Tokya, 113-0033, Japan

  • Kagawa University Hospital

    Kita-gun, Kagawa-ken, 761-0793, Japan

  • Kindai University Hospital

    Sayama, Osaka, 589-8511, Japan

  • Kitasato University Hospital

    Sagamihara, Kanagawa, 252-0374, Japan

  • Kobe University Hospital

    Kobe, Hyōgo, 650-0017, Japan

  • Kumamoto University Hospital

    Kumamoto, 860-8556, Japan

  • Kurume University Hospital

    Kurume, Fukuoka, 830-0011, Japan

  • Kyoto University Hospital

    Kyoto, 606-8507, Japan

  • Kyushu Cancer Center

    Fukuoka, 811-1347, Japan

  • Nara Medical University Hospital

    Kashihara, Nara, 634-8522, Japan

  • National Cancer Center Hospital

    Chuo-ku, Tokyo, 104-0045, Japan

  • Nippon Medical School Hospital

    Bunkyo-ku, Tokyo, 113-8603, Japan

  • Osaka International Cancer Institute

    Osaka, 540-0008, Japan

  • Saitama Medical University International Medical Center

    Hidaka, Saitama, 350-1298, Japan

  • Sapporo Medical University Hospital

    Sapporo, Hokkaido, 060-8648, Japan

  • St. Marianna University Hospital

    Kawasaki, Kanagawa, 216-8511, Japan

  • Teikyo University Hospital

    Itabashi-ku, Tokyo, 173-8606, Japan

  • Tokushima University Hospital

    Tokushima, 770-0042, Japan

  • Toyama University Hospital

    Toyama, 930-0194, Japan

  • University Hospital Kyoto Prefectural University of Medicine

    Kyoto, 602-8566, Japan

  • Yamagata University Hospital

    Yamagata, 9902331, Japan

Conditions

Explore the condition pages connected to this study.

UROTHELIAL CARCINOMA